SEC 13F Intelligence

Rtw Investments, LP / STOK

Rtw Investments, LP’s Stoke Therapeutics Inc Position

Does Rtw Investments, LP own Stoke Therapeutics Inc (STOK)? Yes — 5.62M shares worth $183M (+1.82% of its 13F portfolio) as of Q1 2026, up from 5.55M shares the prior filed quarter.

Position Value
$183M
Q1 2026
Shares
5.62M
% of Portfolio
+1.82%
Quarters Held
28
currently held

Position History STOK

Reported value by quarter
Q2 ’19: $93MQ2 ’19Q3 ’19: $69MQ4 ’19: $100MQ1 ’20: $81MQ2 ’20: $84MQ2 ’20Q3 ’20: $119MQ4 ’20: $219MQ1 ’21: $142MQ2 ’21: $123MQ2 ’21Q3 ’21: $93MQ4 ’21: $87MQ1 ’22: $77MQ2 ’22: $48MQ2 ’22Q3 ’22: $47MQ4 ’22: $36MQ1 ’23: $37MQ2 ’23: $47MQ2 ’23Q3 ’23: $17MQ4 ’23: $22MQ1 ’24: $57MQ2 ’24: $57MQ2 ’24Q3 ’24: $57MQ4 ’24: $57MQ1 ’25: $34MQ2 ’25: $58MQ2 ’25Q3 ’25: $120MQ4 ’25: $176MQ1 ’26: $183Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.62M$183M+1.82%
Q4 20255.55M$176M+1.76%
Q3 20255.12M$120M+1.48%
Q2 20255.12M$58M+0.83%
Q1 20255.12M$34M+0.52%
Q4 20245.12M$57M+0.85%
Q3 20244.65M$57M+0.83%
Q2 20244.22M$57M+0.88%
Q1 20244.22M$57M+0.84%
Q4 20234.13M$22M+0.34%
Q3 20234.39M$17M+0.36%
Q2 20234.39M$47M+0.89%
Q1 20234.39M$37M+0.76%
Q4 20223.87M$36M+0.73%
Q3 20223.65M$47M+1.08%
Q2 20223.65M$48M+1.25%
Q1 20223.64M$77M+1.59%
Q4 20213.64M$87M+1.28%
Q3 20213.64M$93M+1.40%
Q2 20213.64M$123M+1.85%
Q1 20213.64M$142M+2.21%
Q4 20203.54M$219M+3.68%
Q3 20203.54M$119M+2.86%
Q2 20203.54M$84M+2.38%
Q1 20203.54M$81M+3.49%
Q4 20193.54M$100M+3.79%
Q3 20193.36M$69M+4.13%
Q2 20193.36M$93M+4.94%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of STOK.